LeadIQ logo
Learn more at LeadIQ.com

Insights

Key Personnel Development Recent hiring of Dr. Will as Chief Medical Officer and Matthias Will as Chief Development Officer indicates an expansion of leadership team, potentially leading to collaboration opportunities for new product development or partnerships.

Financial Growth Potential Recent financing of $24.6M and revenue in the range of $100M - 1B present financial stability and growth potential for Autolus, making it an attractive partner for investment opportunities.

Technological Innovation Utilization of technologies like Optimise, Cloudflare Bot Management, and Microsoft 365 showcases a commitment to innovation, which can appeal to tech-oriented clients seeking cutting-edge solutions.

Strategic Partnerships Partnerships with renowned institutions like Mayo Clinic for developing novel diagnostic approaches create opportunities for joint ventures, licensing deals, or collaborative research with industry leaders in healthcare.

Investment Attraction Recent investments by Victory Capital Management Inc. and the funding of $350M position Autolus as an attractive investment opportunity for financial firms seeking to diversify portfolios in the biotechnology sector.

Similar companies to Autolus Therapeutics

Autolus Therapeutics Tech Stack

Autolus Therapeutics uses 8 technology products and services including Optimise, WordPress, Zendesk, and more. Explore Autolus Therapeutics's tech stack below.

  • Optimise
    Affiliate Advertising Networks
  • WordPress
    Content Management System
  • Zendesk
    Documentation Tools
  • Microsoft 365
    Email
  • jQuery
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • X-XSS-Protection
    Security
  • YouTube
    Video Players

Media & News

Autolus Therapeutics's Email Address Formats

Autolus Therapeutics uses at least 1 format(s):
Autolus Therapeutics Email FormatsExamplePercentage
F.Last@autolus.comJ.Doe@autolus.com
57%
First.Last@autolus.comJohn.Doe@autolus.com
39%
FirstL@autolus.comJohnD@autolus.com
2%
FirstLast@autolus.comJohnDoe@autolus.com
2%

Frequently Asked Questions

Where is Autolus Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Autolus Therapeutics's main headquarters is located at Autolus Limited London, W12 7RZ GB. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Autolus Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Autolus Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Autolus Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Autolus Therapeutics is a publicly traded company; the company's stock symbol is AUTL.

What is Autolus Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Autolus Therapeutics's official website is autolus.com and has social profiles on LinkedIn.

How much revenue does Autolus Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, Autolus Therapeutics's annual revenue reached $750M.

What is Autolus Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Autolus Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Autolus Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Autolus Therapeutics has approximately 604 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Clinical Officer, Cancer Drug Development; Car-T Immunotherapy: A. S.Chief Business Officer: C. W.Chief Development Officer: E. B.. Explore Autolus Therapeutics's employee directory with LeadIQ.

What industry does Autolus Therapeutics belong to?

Minus sign iconPlus sign icon
Autolus Therapeutics operates in the Biotechnology Research industry.

What technology does Autolus Therapeutics use?

Minus sign iconPlus sign icon
Autolus Therapeutics's tech stack includes OptimiseWordPressZendeskMicrosoft 365jQueryCloudflare Bot ManagementX-XSS-ProtectionYouTube.

What is Autolus Therapeutics's email format?

Minus sign iconPlus sign icon
Autolus Therapeutics's email format typically follows the pattern of . Find more Autolus Therapeutics email formats with LeadIQ.

How much funding has Autolus Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Autolus Therapeutics has raised $350M in funding. The last funding round occurred on Feb 08, 2024 for $350M.

When was Autolus Therapeutics founded?

Minus sign iconPlus sign icon
Autolus Therapeutics was founded in 2014.
Autolus Therapeutics

Autolus Therapeutics

Biotechnology ResearchLondon, United Kingdom501-1000 Employees

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. 

Section iconCompany Overview

Headquarters
Autolus Limited London, W12 7RZ GB
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AUTL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
501-1000

Section iconFunding & Financials

  • $350M

    Autolus Therapeutics has raised a total of $350M of funding over 10 rounds. Their latest funding round was raised on Feb 08, 2024 in the amount of $350M.

  • $100M$1B

    Autolus Therapeutics's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $350M

    Autolus Therapeutics has raised a total of $350M of funding over 10 rounds. Their latest funding round was raised on Feb 08, 2024 in the amount of $350M.

  • $100M$1B

    Autolus Therapeutics's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.